News

Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment
Discover upcoming breakthroughs in Type 1 Diabetes & B-cell disorder treatments, market growth to $24B by 2031, and key ...
American Association of Individual Investors7d
Why Sana Biotechnology, Inc.’s (SANA) Stock Is Down 5.61%
Sana Biotechnology, Inc.’s SANA share price has dipped by 5.61%, which has investors questioning if this is right time to buy ...
Yahoo Finance10d
Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference
Sana Biotechnology, Inc SEATTLE, May 12, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today ...